Featured Research

from universities, journals, and other organizations

Do blood thinners and stroke treatment mean danger? Study indicates risk is low

Date:
March 13, 2013
Source:
University of Michigan Health System
Summary:
Millions of Americans take drugs to reduce their risk of heart attacks caused by blood clots. A new study suggests that a fear of brain bleeding if these patients receive stroke therapy may be unfounded, at least for most patients taking common clot-preventing therapies.

Millions of Americans take aspirin or other drugs every day to reduce their risk of heart attacks or other problems caused by blood clots.

But when one of them suffers a stroke caused by a clot in their brain, some emergency teams might hesitate to give a powerful clot-busting medication called tPA -- for fear that the combination of drugs might cause dangerous brain bleeding.

Now, a University of Michigan Stroke Program study suggests this fear may be unfounded, at least for most patients taking common clot-preventing therapies.

The study is based on data from 830 stroke patients who received tPA at any of the 28 Michigan hospitals that took part in two U-M-led studies. Just under half of them were on aspirin or clopidogrel (sold as Plavix) before they had their strokes.

After adjusting for patients' other characteristics, the researchers found no significant difference in the rate of brain bleeding seen on the patients' brain scans -- even low-level bleeding that didn't cause symptoms.

The results, published in the current issue of Academic Emergency Medicine, should help reassure emergency teams and patients alike that a powerful stroke treatment is safe to use even in patients who have been taking aspirin or clopidogrel.

The findings did show a small increased risk of non-symptomatic brain bleeding in patients over the age of 81. And, when the researchers combined their data with data from other past studies on the topic, they did find a small increased risk but could not adjust the data for all patient characteristics.

The study did not include any patients taking more potent blood thinners, such as warfarin, heparin, dabigatran (Pradaxa) or rivaroxaban (Xarelto). The authors caution that the potential use of tPA in patients taking these drugs needs much more study.

"In light of the long-term benefit that patients receive from antiplatelet therapy, the small increase in risk of intracranial hemorrhage after tPA treatment should not be a game-changer for emergency physicians," says lead author William Meurer, M.D., M.S., an assistant professor of emergency medicine at the U-M Medical School. "This study from a broad range of hospitals provides solid evidence based on real-world use of tPA that physicians should not alter their decision making based on aspirin or clopidogrel use when treating stroke patients with tPA."


Story Source:

The above story is based on materials provided by University of Michigan Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. William J. Meurer, Heemun Kwok, Lesli E. Skolarus, Eric E. Adelman, Allison M. Kade, Jack Kalbfleisch, Shirley M. Frederiksen, Phillip A. Scott. Does Preexisting Antiplatelet Treatment Influence Postthrombolysis Intracranial Hemorrhage in Community-treated Ischemic Stroke Patients? An Observational Study. Academic Emergency Medicine, 2013; 20 (2): 146 DOI: 10.1111/acem.12077

Cite This Page:

University of Michigan Health System. "Do blood thinners and stroke treatment mean danger? Study indicates risk is low." ScienceDaily. ScienceDaily, 13 March 2013. <www.sciencedaily.com/releases/2013/03/130313095301.htm>.
University of Michigan Health System. (2013, March 13). Do blood thinners and stroke treatment mean danger? Study indicates risk is low. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2013/03/130313095301.htm
University of Michigan Health System. "Do blood thinners and stroke treatment mean danger? Study indicates risk is low." ScienceDaily. www.sciencedaily.com/releases/2013/03/130313095301.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins